
Sie haben einen Link angeklickt, der auf eine andere Website führt. Wenn Sie fortfahren, verlassen
Sie diese Website und werden zu einer Website weitergeleitet, die außerhalb unseres Verantwortungsbereichs liegt. Medtronic Deutschland prüft oder kontrolliert den Inhalt von Websites nicht, die außerhalb unseres Verantwortungsbereichs liegen. Wir haften nicht für geschäftliche Vorgänge oder Abschlüsse, die Sie auf solchen fremden Websites tätigen. Ihre Nutzung fremder Websites unterliegt den Nutzungsbedingungen und den Datenschutzbestimmungen der jeweiligen Website.
Ihr Browser ist nicht auf dem aktuellen Stand.
Mit einem aktualisierten Browser können Sie die Website von Medtronic besser nutzen. Browser jetzt aktualisieren.
Dieser Bereich unserer Website richtet sich an Angehörige der medizinischen Fachkreise (Ärzte, Pflegeberufe, Krankenhausverwaltung, Krankenkassen etc.).
Patienten finden Informationen hier.
Answer a few questions to help determine whether a specialised consultation could help your patient.
Assess Spasticity is a questionnaire consisting of ten questions that may help identify potential candidates for a screening test or whether patients would benefit from a specialised consultation where spasticity can be further evaluated. Recommendations are based on best practices1 and expert guidance2,3. Although the recommendations are the result of a careful and scientifically validated approach, they still reflect recommendations and should not be interpreted as a 'gold standard' for any given patient. The programme should be viewed as a 'professional mirror' to compare your own decisions with the best practices and expert guidance. The programme is meant to assist you in forming your medical judgment but should not interfere with your independent diagnosis and treatment decision. The indicated programme recommendation for a given patient should not preclude a final decision to be made by you or a competent medical team in a specialised centre for spasticity therapy, as to whether the therapy should be recommended or not.
The use of Intrathecal Drug Delivery for spasticity is not for everyone. Not everyone will receive the same results.
Saulino M., Ivanhoe C.B., McGuire J.R., Ridley B., Shilt J.S., Boster A.L. Neuromodulation 2016 Aug;19(6):607-15.
Lanig IS, New PW, Burns AS, Optimizing the Management of Spasticity in People With Spinal Cord Damage: A Clinical Care Pathway for Assessment and Treatment Decision Making From the Ability Network, an International Initiative. Arch Phys Med Rehabil. 2018 Aug;99(8):1681-1687
Ivanhoe CB, Tilton AH, Francisco GE. Phys Med Rehabil Clin N Am. 2001 Nov; 12(4); 923-38, viii-ix.
Refer to the drug manufacturer's package insert for a complete list of indication, contraindication, warning, precautions, adverse events and dosage and administration information.
See the device maual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precaustions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.
For applicable products consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.